These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19679874)

  • 1. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.
    Buhimschi CS; Baumbusch MA; Dulay AT; Oliver EA; Lee S; Zhao G; Bhandari V; Ehrenkranz RA; Weiner CP; Madri JA; Buhimschi IA
    Am J Pathol; 2009 Sep; 175(3):958-75. PubMed ID: 19679874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
    Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
    World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE does not contribute to renal injury and damage upon ischemia/reperfusion-induced injury.
    Dessing MC; Pulskens WP; Teske GJ; Butter LM; van der Poll T; Yang H; Tracey KJ; Nawroth PP; Bierhaus A; Florquin S; Leemans JC
    J Innate Immun; 2012; 4(1):80-5. PubMed ID: 22067944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Mobility Group-Box 1 (HMGB1) levels are increased in amniotic fluid of women with intra-amniotic inflammation-determined preterm birth, and the source may be the damaged fetal membranes.
    Baumbusch MA; Buhimschi CS; Oliver EA; Zhao G; Thung S; Rood K; Buhimschi IA
    Cytokine; 2016 May; 81():82-7. PubMed ID: 26954343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Receptor for Advanced Glycation End-Products (RAGE) Signaling on Intestinal Ischemic Damage in Mice.
    Makino Y; Munakata S; Ueyama T; Honjo K; Kawano S; Takahashi M; Kojima Y; Tomiki Y; Sakamoto K
    Eur Surg Res; 2019; 60(5-6):239-247. PubMed ID: 31914449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
    Abe H; Okada-Tsuchioka M; Kajitani N; Omori W; Itagaki K; Shibasaki C; Boku S; Matsuhisa T; Takebayashi M
    Neuropsychopharmacol Rep; 2023 Sep; 43(3):359-364. PubMed ID: 37337402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2.
    Monden M; Koyama H; Otsuka Y; Morioka T; Mori K; Shoji T; Mima Y; Motoyama K; Fukumoto S; Shioi A; Emoto M; Yamamoto Y; Yamamoto H; Nishizawa Y; Kurajoh M; Yamamoto T; Inaba M
    Diabetes; 2013 Feb; 62(2):478-89. PubMed ID: 23011593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
    Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
    Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting RAGE Signaling in Inflammatory Disease.
    Hudson BI; Lippman ME
    Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of sRAGE, HMGB1, AGE, and S100A8/A9 Concentrations in Plasma and in Serum-Extracted Extracellular Vesicles of Pregnant Women With Preterm Premature Rupture of Membranes.
    Bouvier D; Giguère Y; Blanchon L; Bujold E; Pereira B; Bernard N; Gallot D; Sapin V; Forest JC
    Front Physiol; 2020; 11():609. PubMed ID: 32655405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
    Good DW; George T; Watts BA
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alarmins and Related Molecules in Elective Surgery.
    Strohalmová S; Levová K; Kuběna AA; Hoskovec D; Krška Z; Zima T; Kalousová M
    Folia Biol (Praha); 2023; 69(2):50-58. PubMed ID: 38063001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
    Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
    Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury.
    Fan H; Tang HB; Chen Z; Wang HQ; Zhang L; Jiang Y; Li T; Yang CF; Wang XY; Li X; Wu SX; Zhang GL
    J Neuroinflammation; 2020 Oct; 17(1):295. PubMed ID: 33036632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
    Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
    Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
    Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
    Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.
    Huebener P; Pradere JP; Hernandez C; Gwak GY; Caviglia JM; Mu X; Loike JD; Schwabe RF
    J Clin Invest; 2015 Feb; 125(2):539-50. PubMed ID: 25562324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.